Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemcitabine, Capecitabine and Avastin in Pancreatic Cancer
NCT00100815Phase 2Completed
- Sponsor
- Roswell Park Comprehensive Cancer Center
- Start
- Aug 2004
- Primary completion
- Aug 2008
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab in pancreatic cancer (PC), sponsored by Roswell Park Comprehensive Cancer Center. Started Aug 2004; status: completed.
02
Drugs
bevacizumab
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT00100815.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00100815.